Hector Casab is a finance executive with expertise in managing companies for growth and value creation. Hector is now a consulting CFO to biotech and health tech companies in the Bay Area. He is Board Member of the NorCal chapter Association of Bioscience Financial Officers, which provides a forum for the senior financial executives of more than 100 Bay Area life science companies to discuss business and financial issues related to the industry. He is Founder, Director and CEO of the Benjamin Links Foundation, a non-profit that provide services to children with autism, their families and their communities. Previously, he was CFO / VP of Finance at ForSight VISION5 (private, acquired by Allergan); Vice President of Finance & Administration at Icon Bioscience; Head of Financial Planning at Onyx Pharmaceuticals (public, acquired by Amgen). During his five-plus year tenure at Genentech (public, acquired by Roche), his multiple roles included Director, Corporate Planning, Director, Global Supply Chain Finance, and Associate Director, Manufacturing Collaborations Finance. He was previously with Applied Biosystems (public, acquired by Invitrogen to form Life Technologies), serving in various roles in operations and finance. He holds an MBA from Santa Clara University with a concentration in Marketing and Finance, and a B.S. from Oakland University in Accounting and Management Information Systems.